A blow for AstraZeneca vaccine, touted as world's best hope for defeating Covid-19
South Africa has paused its rollout of the Oxford-AstraZeneca coronavirus vaccine after a study showed that it offered "minimal protection" against mild or moderate illness caused by the more contagious virus variant first identified there, known as B.1.351.